| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/05/2007 | WO2007074198A1 Selective peptides that inhibit the biological activity of calcineurin |
| 07/05/2007 | WO2007073907A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 07/05/2007 | WO2007073706A2 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 07/05/2007 | WO2007073661A1 Activated collagen scaffold materials and their special fused active restoration factors |
| 07/05/2007 | WO2007057490A3 Immunogenic polypeptides of presenilin-1-associated protein (psap), methods of obtaining antibodies and use of same |
| 07/05/2007 | WO2007049805A8 Synthetic lipopeptide and use thereof for medical purposes |
| 07/05/2007 | WO2007044321A3 Latent procytotoxins and uses thereof |
| 07/05/2007 | WO2007039318A3 Neuropeptide y analogs |
| 07/05/2007 | WO2007039256A3 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 07/05/2007 | WO2007038703A3 Il-17a and il-17f antagonists and methods of using the same |
| 07/05/2007 | WO2007038402A9 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas |
| 07/05/2007 | WO2007023476A3 Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |
| 07/05/2007 | WO2007013358A3 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 07/05/2007 | WO2007011363A3 Binding domain fusion proteins |
| 07/05/2007 | WO2007000320A3 Method for diagnosing rheumatic diseases |
| 07/05/2007 | WO2006116442A3 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 07/05/2007 | WO2006076711A3 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials |
| 07/05/2007 | WO2006021210A3 Binding member towards pneumolysin |
| 07/05/2007 | WO2005023992A3 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 07/05/2007 | WO2004083381A3 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 07/05/2007 | WO2004069183A3 Immune regulation based on the targeting of early activation molecules |
| 07/05/2007 | WO2004064479A3 Neuroprotective therapeutics and assays for identifying the same |
| 07/05/2007 | WO2003066821A3 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same |
| 07/05/2007 | WO2002038805A8 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 07/05/2007 | US20070157344 Signal Transduction Stress-Related Proteins and Methods of Use in Plants |
| 07/05/2007 | US20070157343 Transcription Factor Stress-Related Proteins and Methods of Use in Plants |
| 07/05/2007 | US20070157341 nucleic acid fragment coding flowering locus t (FT) for use as tool in generating plants wijth enhanced shoot and flower development |
| 07/05/2007 | US20070157335 Altering Protein Functional Properties Through Terminal Fusions |
| 07/05/2007 | US20070157334 Protein Kinase Stress-Related Proteins and Methods of Use in Plants |
| 07/05/2007 | US20070157328 Suppression of xenotransplant rejection |
| 07/05/2007 | US20070157327 Parkin interacting polypeptides and methods of use |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070157050 Process for providing submodel performance in a computer processing unit |
| 07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/05/2007 | US20070155958 Tnf-like secreted protein |
| 07/05/2007 | US20070155957 Crystals of MarR polypeptides, regulators of multiple antibiotic resistance |
| 07/05/2007 | US20070155956 Preparation of antifreeze protein |
| 07/05/2007 | US20070155955 Amylin aggregation inhibitors and use thereof |
| 07/05/2007 | US20070155658 Complexed via melamine derivative and optionally polyarginine or a polymer of glutamine and asparagine; RNA interference |
| 07/05/2007 | US20070155654 Novel formulations |
| 07/05/2007 | US20070155013 Pluripotent stem cell growing method |
| 07/05/2007 | US20070155008 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 07/05/2007 | US20070155002 Amino acid sequence from active principles in musk and their acetic salts, preparation and use thereof |
| 07/05/2007 | US20070154997 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 07/05/2007 | US20070154994 protein of an ectodomain of a transforming growth factor beta membrane-bound receptor and a peptide subunit of an alpha -helical coiled-coil; selecting compounds capable of inhibiting ligand binding and kinase activity |
| 07/05/2007 | US20070154993 Enhancing Recombinant Hemoglobin Production By Co-Expression With Alpha Hemoglobin Stabilizing Protein |
| 07/05/2007 | US20070154992 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| 07/05/2007 | US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A |
| 07/05/2007 | US20070154988 Bacterial bioreactor for propagation of enzymatic polypeptides |
| 07/05/2007 | US20070154986 Streptococcus pneumoniae Polynucleotides and Sequences |
| 07/05/2007 | US20070154985 by expression of a nucleic acid encoding NK polypeptide in a microbial host cell, isolating inclusion bodies containing the NK polypeptide in denatured form, solubilization of the inclusion bodies and naturation of the denatured NK polypeptide |
| 07/05/2007 | US20070154983 Methods of in vitro protein synthesis |
| 07/05/2007 | US20070154982 Mammalian cell lines modified for the production of recombinant glycoproteins |
| 07/05/2007 | US20070154981 Insulin-producing cells derived from stem cells |
| 07/05/2007 | US20070154972 immunogens, monoclonal antibodies which bind selectively to 5-fluoro-uracil and have cross-reactivity with uracil, cytosine and tegafur; for rapidly determining optimal drug concentrations during chemotherapy |
| 07/05/2007 | US20070154957 detecting the presence of a midbody scar in a mammalian cell using mitotic kinesin-like protein 1 (MKLP1), Epsilon tubulin ( epsilon -tubulin), Centrosomal Protein 55 kDa (Cep55) or Aurora B kinase; proliferative disorder |
| 07/05/2007 | US20070154949 Monoclonal antibody specific to truncated midkine (tmk) protein and uses thereof |
| 07/05/2007 | US20070154933 Reagents and Methods for Identifying Gene Targets for Treating Cancer |
| 07/05/2007 | US20070154928 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 07/05/2007 | US20070154920 For detecting and/or treating allergic dermatitis |
| 07/05/2007 | US20070154918 44 Human Secreted Proteins |
| 07/05/2007 | US20070154917 Compositions and method for treating viral infections |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154911 Regulatory protein pke#83 from human keratinocytes |
| 07/05/2007 | US20070154910 50 Human Secreted Proteins |
| 07/05/2007 | US20070154908 Connective Tissue Growth Factor-2 |
| 07/05/2007 | US20070154905 Modulators of the function of fas receptors and other proteins |
| 07/05/2007 | US20070154902 Papilloma virus vaccine |
| 07/05/2007 | US20070154901 Comprising tetranectin trimerising structural element (TTSE) capable of forming a stable complex with two other TTSEs; stability; used as a carrier of other chemical entities; drug delivery |
| 07/05/2007 | US20070154886 Composition, splice variants and methods relating to ovarian specific genes and proteins |
| 07/05/2007 | US20070154884 Assessment of human papilloma virus-related disease |
| 07/05/2007 | US20070154880 Process for the preparation and purification of recombinant proteins |
| 07/05/2007 | US20070154552 Biologically active native biomatrix composition |
| 07/05/2007 | US20070154529 Uses of dna binding proteins |
| 07/05/2007 | US20070154517 Methods and devices for promoting endothelial morphogenesis |
| 07/05/2007 | US20070154496 Lolium perenne (Lol p 1) polypeptide for use as diagnostic/prognostic indicator or allergic reactions |
| 07/05/2007 | US20070154489 Infectious bronchitis virus with an altered spike gene |
| 07/05/2007 | US20070154488 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154485 Anticancer agents using verotoxin variants |
| 07/05/2007 | US20070154474 Human Prostate Specific G-Protein Receptor HPRAJ70 |
| 07/05/2007 | US20070154464 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell |
| 07/05/2007 | US20070154453 have alterations in the IL-12p40 subunit to eliminate the protease site between positions Lys260 and Arg261; cancer, antiinflamatories |
| 07/05/2007 | US20070154446 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 07/05/2007 | US20070154437 Peptide-tagged proteins and methods of making and using thereof |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | US20070154391 Monoclonal antibodies; hybridomas; competitive binding |
| 07/05/2007 | CA2836123A1 Compositions and methods for producing a composition |
| 07/05/2007 | CA2673593A1 Immunologically enhanced recombinant vaccines |
| 07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | CA2635726A1 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 07/05/2007 | CA2635456A1 Histidine-containing diastereomeric peptides and uses thereof |
| 07/05/2007 | CA2635214A1 Compounds useful in cftr assays and methods therewith |
| 07/05/2007 | CA2635127A1 Method for the analysis of differential expression in colorectal cancer |
| 07/05/2007 | CA2634955A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 07/05/2007 | CA2634760A1 Compositions and methods for producing a composition |
| 07/05/2007 | CA2634547A1 Stable ctla4 formulation for subcutaneous administration |
| 07/05/2007 | CA2634544A1 Methods and compositions for increasing the nitrogen storage capacity of a plant |
| 07/05/2007 | CA2634067A1 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 07/05/2007 | CA2634016A1 Compositions and methods for treating obesity and related metabolic disorders |